Abstract:Objective This study endeavored to explore the optimal treatment strategy and conduct a prognostic analysis for patients diagnosed with pT4M0 (pathologic stage T4) colon adenocarcinoma (COAD). Methods and materials A total of 8,843 patients diagnosed with pT4M0 COAD between January 2010 and December 2015 were included in this study from the Surveillance, Epidemiology, and End Results (SEER) database. These patients were randomly divided into a training set and an internal validation set using a 7:3 ratio. Variables that demonstrated statistical significance (P<0.05) in univariate COX regression analysis or held clinical significance were incorporated into the multivariate COX regression model. Subsequently, this model was utilized to formulate a nomogram. The predictive accuracy and discriminability of the nomogram were assessed using the C-index, area under the curve (AUC), and calibration curves. Decision curve analysis (DCA) was conducted to confirm the clinical validity of the model. Results In the entire SEER cohort, the 3-year overall survival (OS) rate (74.22% vs. 63.20%, P<0.001) and the 3-year cancer-specific survival (CSS) rate (76.25% vs. 66.98%, P<0.001) in the surgery combined with postoperative adjuvant therapy (S+ADT) group surpassed those in the surgery (S) group. Multivariate COX regression analysis of the training set unveiled correlations between age, race, N stage, serum CEA (carcinoembryonic antigen), differentiation, number of resected lymph nodes, and treatment modalities with OS and CSS. Nomograms for OS and CSS were meticulously crafted based on these variables, achieving C-indexes of 0.692 and 0.690 in the training set, respectively. The robust predictive ability of the nomogram was further affirmed through receiver operating characteristic (ROC) and calibration curves in both the training and validation sets. Conclusion In individuals diagnosed with pT4M0 COAD, the integration of surgery with adjuvant chemoradiotherapy demonstrated a substantial extension of long-term survival. The nomogram, which incorporated key factors such as age, race, differentiation, N stage, serum CEA level, tumor size, and the number of resected lymph nodes, stood as a dependable tool for predicting OS and CSS rates. This predictive model held promise in aiding clinicians by identifying high-risk patients and facilitating the development of personalized treatment plans.

The Association Between Small Tumor Size and Poor Survival in T4 Mucinous Adenocarcinoma of Colon Without Distant Metastasis.

Smaller Tumor Size is Associated with Poor Survival in T4b Colon Cancer.

Smaller Tumor Size is Associated with Poor Survival in Stage II Colon Cancer: an Analysis of 7,719 Patients in the SEER Database.

Impact of tumour size on metastasis and survival in patients with pancreatic neuroendocrine tumours (PNETs): A population based study.

Ulcer Size as a Novel Indicator Marker Is Correlated with Prognosis of Ulcerative Gastric Cancer

Survival of Patients with Resected Primary Colorectal Mucinous Adenocarcinoma: A Competing Risk Nomogram Analysis.

Tumour size and overall survival among surgically treated patients with non‐metastatic colon cancer in the U.S. Military Health System

Prognostic Value of Tumor Size in Colon Cancer-Smaller is Better?

Does tumor size have its prognostic role in colorectal cancer? Re-evaluating its value in colorectal adenocarcinoma with different macroscopic growth pattern.

Evaluating the Effect of Lymph Node Status on Survival in Large Colon Cancer

Clinicopathological characteristics and outcomes of colorectal mucinous adenocarcinoma: a retrospective analysis from China

Effect of Large Tumor Size on Cancer-Specific Mortality in Node-Negative Breast Cancer.

The Correlation Between Tumor Size, Lymph Node Status, Distant Metastases And Mortality In Rectal Cancer Patients Without Neoadjuvant Therapy

The impact of tumor size on the prognosis and chemotherapy efficacy in stage I/II colon cancer patients

Prognostic Significance of Tumor Size for Primary Invasive Cutaneous Melanoma: A Population‐based Study, 2004‐2016

Value of tumor size as a prognostic factor in metastatic colorectal cancer patients after chemotherapy: a population-based study.

Tumor Size is Associated with Adjuvant Chemotherapy Benefit in T1N0M0 Triple-Negative Breast Cancer: a Multicenter and Propensity Score Matched Analysis.

Effect of tumor size on prognosis of node-negative lung cancer with sufficient lymph node examination and no disease extension.

Influence of tumor size on the prognosis in patients with colon cancer

Optimal treatment strategy and prognostic analysis for patients with non-metastatic pT4 colon adenocarcinoma

Prognostic Value of the Tumor Size in Resectable Colorectal Cancer with Different Primary Locations: A Retrospective Study with the Propensity Score Matching